Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03990896
Title Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Massachusetts General Hospital
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UCSF Medical Center-Mission Bay/Benioff Children's Hospital RECRUITING San Francisco California 94143 United States Details
Emory University Winship Cancer Institute RECRUITING Atlanta Georgia 30322 United States Details
Northwestern University RECRUITING Chicago Illinois 60611 United States Details
Massachusetts General Hospital Cancer Center RECRUITING Boston Massachusetts 02114 United States Details
Weill Cornell Medicine RECRUITING New York New York 10065 United States Details
Vanderbilt University RECRUITING Nashville Tennessee 37232-6307 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field